Female contraceptive clinical trial: a randomized controlled study of the efficacy, safety, & acceptability of C31G

Ended Awarded Last action

Contract number
HHSN275200900095U
Awardee
Awarding agency
Obligated
$1,417,835

Award facts

Opportunity
  • RFPNICHD200304 Solicitation number
Contract value 100% obligated
$1,417,834.56 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Competitive Delivery Order · 11 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Los Angeles, CA 90010, USA
Legislative mandates
  • Other statutory authority

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 5 -$2
Change Order 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Funding Only Action 1 · Female path condom $888,502
Original award $529,335

Quick answers

Who was awarded contract HHSN275200900095U?

HHSN275200900095U was awarded to Essential Access Health by National Institute of Child Health and Human Development (National Institutes of Health) on September 30, 2009.

How much is contract HHSN275200900095U worth?

The government has obligated $1,417,835 on HHSN275200900095U.

Is contract HHSN275200900095U an order under another contract?

Yes. HHSN275200900095U is a delivery order under HHSN275200403381I, an indefinite delivery contract.

Was contract HHSN275200900095U competed?

The extent of competition for HHSN275200900095U was competitive delivery order. The government received 11 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login